New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
October 28, 2009
07:06 EDTAUXL
theflyonthewall.com: Auxilium Pharma reports Q3 EPS (35c) vs. consensus of (31c)
:theflyonthewall.com



News For AUXL From The Last 14 Days
Check below for free stories on AUXL the last two weeks.
There are 4 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 9, 2012
16:27 EDTAUXL
theflyonthewall.com: Leerink's biotech and pharmaceuticals analysts hold a conference call
Biotech Analysts Schimmer and Liang, along with Pharmaceuticals Analyst Fernandez, review the reimbursement process for drugs in France on an Analyst/Industry conference call. Relevant covered companies ACOR, AMGN, AMLN, AUXL, BIIB, BMY, GILD, HGSI, ITMN, JNJ, NVS, PFE and VRTX may be included on the Analyst/Industry conference call to be held on February 10 at 11 am. :theflyonthewall.com

February 6, 2012
09:17 EDTAUXL
theflyonthewall.com: Auxilium announces appointments to enhance leadership team

Subscribe for More Information
:theflyonthewall.com

February 1, 2012
14:12 EDTAUXL
theflyonthewall.com: Auxilium removed from short-term buy list at Deutsche Bank
:theflyonthewall.com
09:41 EDTAUXL
theflyonthewall.com: Auxilium recieves cautious assessment for Xiaflex, says Leerink
Leerink said the IQWiG released its assessment for Auxilium's/Pfizer's (PFE) Xiaflex for Dupuytren's contracture and Esai's Halavan for breast cancer. The firm said both received a "no proven added benefit" assessment and views the decision as concerning for the drugs and believes it reduces visibility into German reimbursement. :theflyonthewall.com